| 43063-903-30 |
43063-903 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20181114 |
N/A |
ANDA |
ANDA209312 |
PD-Rx Pharmaceuticals, Inc. |
METHOCARBAMOL |
500 mg/1 |
30 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-903-30) |
| 43063-905-14 |
43063-905 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20181108 |
N/A |
ANDA |
ANDA209312 |
PD-Rx Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
14 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-14) |
| 43063-905-20 |
43063-905 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20181108 |
N/A |
ANDA |
ANDA209312 |
PD-Rx Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
20 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-20) |
| 43063-905-30 |
43063-905 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20181108 |
N/A |
ANDA |
ANDA209312 |
PD-Rx Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
30 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-30) |
| 43063-905-40 |
43063-905 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20181112 |
N/A |
ANDA |
ANDA209312 |
PD-Rx Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
40 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-40) |
| 43063-905-60 |
43063-905 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20190109 |
N/A |
ANDA |
ANDA209312 |
PD-Rx Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
60 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-905-60) |
| 70518-4501-0 |
70518-4501 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20251013 |
N/A |
ANDA |
ANDA209312 |
REMEDYREPACK INC. |
METHOCARBAMOL |
750 mg/1 |
40 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-4501-0) |
| 60760-592-30 |
60760-592 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20250422 |
N/A |
ANDA |
ANDA209312 |
ST. MARY'S MEDICAL PARK PHARMACY |
METHOCARBAMOL |
500 mg/1 |
30 TABLET, COATED in 1 BOTTLE, PLASTIC (60760-592-30) |
| 60760-592-60 |
60760-592 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20240819 |
N/A |
ANDA |
ANDA209312 |
ST. MARY'S MEDICAL PARK PHARMACY |
METHOCARBAMOL |
500 mg/1 |
60 TABLET, COATED in 1 BOTTLE, PLASTIC (60760-592-60) |
| 60760-592-90 |
60760-592 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20230420 |
N/A |
ANDA |
ANDA209312 |
ST. MARY'S MEDICAL PARK PHARMACY |
METHOCARBAMOL |
500 mg/1 |
90 TABLET, COATED in 1 BOTTLE, PLASTIC (60760-592-90) |
| 76420-893-01 |
76420-893 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20250128 |
N/A |
ANDA |
ANDA209312 |
Asclemed USA, Inc. |
METHOCARBAMOL |
500 mg/1 |
100 TABLET, COATED in 1 BOTTLE (76420-893-01) |
| 76420-893-05 |
76420-893 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20250128 |
N/A |
ANDA |
ANDA209312 |
Asclemed USA, Inc. |
METHOCARBAMOL |
500 mg/1 |
500 TABLET, COATED in 1 BOTTLE (76420-893-05) |
| 76420-893-12 |
76420-893 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20250128 |
N/A |
ANDA |
ANDA209312 |
Asclemed USA, Inc. |
METHOCARBAMOL |
500 mg/1 |
120 TABLET, COATED in 1 BOTTLE (76420-893-12) |
| 76420-893-30 |
76420-893 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20250128 |
N/A |
ANDA |
ANDA209312 |
Asclemed USA, Inc. |
METHOCARBAMOL |
500 mg/1 |
30 TABLET, COATED in 1 BOTTLE (76420-893-30) |
| 76420-893-60 |
76420-893 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20250128 |
N/A |
ANDA |
ANDA209312 |
Asclemed USA, Inc. |
METHOCARBAMOL |
500 mg/1 |
60 TABLET, COATED in 1 BOTTLE (76420-893-60) |
| 76420-893-90 |
76420-893 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20250128 |
N/A |
ANDA |
ANDA209312 |
Asclemed USA, Inc. |
METHOCARBAMOL |
500 mg/1 |
90 TABLET, COATED in 1 BOTTLE (76420-893-90) |
| 67296-2197-1 |
67296-2197 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20200201 |
N/A |
ANDA |
ANDA209312 |
Redpharm Drug |
METHOCARBAMOL |
500 mg/1 |
15 TABLET, COATED in 1 BOTTLE (67296-2197-1) |
| 67296-2197-2 |
67296-2197 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20200201 |
N/A |
ANDA |
ANDA209312 |
Redpharm Drug |
METHOCARBAMOL |
500 mg/1 |
40 TABLET, COATED in 1 BOTTLE (67296-2197-2) |
| 67296-2197-3 |
67296-2197 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20200201 |
N/A |
ANDA |
ANDA209312 |
Redpharm Drug |
METHOCARBAMOL |
500 mg/1 |
30 TABLET, COATED in 1 BOTTLE (67296-2197-3) |
| 67296-2203-1 |
67296-2203 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20200201 |
N/A |
ANDA |
ANDA209312 |
Redpharm Drug |
METHOCARBAMOL |
750 mg/1 |
15 TABLET, COATED in 1 BOTTLE (67296-2203-1) |